Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

Genetic Variants Influencing Spironolactone Effectiveness: A Pharmacogenomic Perspective

Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan · Vol. 14 No. 1 (2026) · hlm. 10–20

DOI
10.22437/jmj.v14i1.43475
ISSN
2580-6874, 2339-269X
Terbit
2026-05-05
Penerbit
FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI
Bahasa
en

Abstrak

Background: Spironolactone, a mineralocorticoid receptor antagonist, is widely used to treat resistant hypertension, heart failure, and primary aldosteronism. However, significant interindividual variability in therapeutic response suggests a genetic contribution to its effectiveness. Method: This study employed a bioinformatics approach using secondary data from PharmGKB, GTEx Portal, and HaploReg v4.2 to identify genetic variants and gene expression profiles potentially influencing spironolactone response. Result: Seven variants were identified as associated with spironolactone effectiveness: rs1799752 (ACE), rs3890011 and rs1126742 (CYP4A11), rs1801253 (ADRB1), rs1799983 (NOS3), rs4961 (ADD1), and rs1042713 (ADRB2). Tissue-specific expression analysis showed ACE highly expressed in testis, CYP4A11 in liver, ADRB1 in lung, NOS3 in spleen, ADD1 in tibial artery, and ADRB2 in skin. Functional predictions indicated that missense variants (rs1126742, rs1799983, rs4961) may affect protein structure, while intronic variants (rs1799752, rs3890011) may influence gene regulation. Conclusion: These findings suggest that pharmacogenomic profiling may help predict spironolactone response and support the development of personalized treatment strategies. Further clinical validation is required to establish the therapeutic relevance of these variants

Kata kunci

Jaringan kolaborasi para penulis

10 penulis · 31 tautan kepenulisan bersama · 13 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Ahmad Dahlan
  • Universitas Alma Ata
  • Sekolah Tinggi Ilmu Kesehatan Samarinda
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Dwi UtamiUniversitas Ahmad Dahlan1
Sapto YulianiUniversitas Ahmad Dahlan1
Wahyu WidyaningsihUniversitas Ahmad Dahlan1
Laela Hayu NuraniUniversitas Ahmad Dahlan1
Moch. Saiful BachriUniversitas Ahmad Dahlan1
Muhammad Marwan RamadhanSekolah Tinggi Ilmu Kesehatan Samarinda1
Nadia Putri AiniyahUniversitas Ahmad Dahlan1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://online-journal.unja.ac.id/index.php/kedokteran/oai, pertama di-harvest 6 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Genetic Variants Influencing Spironolactone Effectiveness: A Pharmacogenomic Perspective</dc:title>
	<dc:creator xml:lang="en">Amukti, Danang Prasetyaning</dc:creator>
	<dc:creator xml:lang="en">Pratami, Ria Indah</dc:creator>
	<dc:creator xml:lang="en">Ananda, RA Dewinta Sukma</dc:creator>
	<dc:subject xml:lang="en">Spironolactone</dc:subject>
	<dc:subject xml:lang="en">Pharmacogenomics</dc:subject>
	<dc:subject xml:lang="en">Genetic Variants</dc:subject>
	<dc:subject xml:lang="en">Gene Expression</dc:subject>
	<dc:subject xml:lang="en">Bioinformatics</dc:subject>
	<dc:description xml:lang="en">Background: Spironolactone, a mineralocorticoid receptor antagonist, is widely used to treat resistant hypertension, heart failure, and primary aldosteronism. However, significant interindividual variability in therapeutic response suggests a genetic contribution to its effectiveness.
Method: This study employed a bioinformatics approach using secondary data from PharmGKB, GTEx Portal, and HaploReg v4.2 to identify genetic variants and gene expression profiles potentially influencing spironolactone response.
Result: Seven variants were identified as associated with spironolactone effectiveness: rs1799752 (ACE), rs3890011 and rs1126742 (CYP4A11), rs1801253 (ADRB1), rs1799983 (NOS3), rs4961 (ADD1), and rs1042713 (ADRB2). Tissue-specific expression analysis showed ACE highly expressed in testis, CYP4A11 in liver, ADRB1 in lung, NOS3 in spleen, ADD1 in tibial artery, and ADRB2 in skin. Functional predictions indicated that missense variants (rs1126742, rs1799983, rs4961) may affect protein structure, while intronic variants (rs1799752, rs3890011) may influence gene regulation.
Conclusion: These findings suggest that pharmacogenomic profiling may help predict spironolactone response and support the development of personalized treatment strategies. Further clinical validation is required to establish the therapeutic relevance of these variants</dc:description>
	<dc:publisher xml:lang="en">FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI</dc:publisher>
	<dc:date>2026-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://online-journal.unja.ac.id/kedokteran/article/view/43475</dc:identifier>
	<dc:identifier>10.22437/jmj.v14i1.43475</dc:identifier>
	<dc:source xml:lang="en">Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan; Vol. 14 No. 1 (2026): JAMBI MEDICAL JOURNAL: Jurnal Kedokteran dan Kesehatan; 10-20</dc:source>
	<dc:source>2580-6874</dc:source>
	<dc:source>2339-269X</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://online-journal.unja.ac.id/kedokteran/article/view/43475/24309</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan</dc:rights>
</oai_dc:dc>